Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials

Published:2017-06-27 Issue:7 Volume:22 Page:1313-1319
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Chen Wang-Chun¹,Huang Chi-Hsien²³,Sheu Chau-Chyun⁴⁵⁶,Chong Inn-Wen⁴⁶⁷,Chu Kuo-An⁸,Chen Yung-Che⁹,Tsai Jong-Rung⁴⁶¹⁰,Lee Cheng-Hung¹¹,Wei Yu-Feng¹²¹³^ORCID

Affiliation:

1. Department of Pharmacy; E-Da Hospital, I-Shou University; Kaohsiung Taiwan

2. Department of Family Medicine; E-Da Hospital, I-Shou University; Kaohsiung Taiwan

3. Center for Evidence-Based Medicine and Center for Meta-Analysis Research; E-Da Hospital, I-Shou University; Kaohsiung Taiwan

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan

5. Department of Internal Medicine, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

6. Research Center for Environmental Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

7. Department of Respiratory Therapy and Graduate Institute of Medicine, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

8. Division of Chest Medicine, Department of Internal Medicine; Kaohsiung-Veterans General Hospital; Kaohsiung Taiwan

9. Division of Pulmonary and Critical Care Medicine; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine; Kaohsiung Taiwan

10. Department of Respiratory Therapy, College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan

11. Division of Chest Medicine, Department of Internal Medicine; National Cheng Kung University Hospital; Tainan Taiwan

12. Institute of Biotechnology and Chemical Engineering; I-Shou University; Kaohsiung Taiwan

13. Division of Pulmonary Medicine, Department of Internal Medicine; E-Da Hospital, I-Shou University; Kaohsiung Taiwan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13100/fullpdf

Reference33 articles.

1. Ten leading causes of death in Taiwan: a comparison of two grouping lists;Hsiao;J. Formos. Med. Assoc.,2015

2. A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD;Calzetta;Chest,2016

3. Efficacy and safety of long-acting beta-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis;Oba;Thorax,2016

4. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary;Vogelmeier;Respirology,2017

5. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease;Chong;Cochrane Database Syst. Rev.,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer’s Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis;Journal of Alzheimer's Disease;2024-01-30

2. COPD‐X Australian guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2022 update;Medical Journal of Australia;2022-09-18

3. Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations;Journal of the Formosan Medical Association;2021-10

4. Optimisation du traitement médicamenteux des patients atteints de BPCO en état stable. Position de la Société de pneumologie de langue française. Actualisation 2021;Revue des Maladies Respiratoires;2021-05

5. Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease;Clinics in Chest Medicine;2020-09